BIRC5 and ovarian carcinoma: A total of 18 studies [7,21,22,23,24,25,26,27,28,29,31,32,33,34,35,36,37,38] reported survivin expression in ovarian cancer, including 1540 (69%) cases of the total 2233 ovarian cancer patients.